共 50 条
- [31] EFFICACY OF HIGH-DOSE AND INTERMEDIATE-DOSE ARA-C IN PATIENTS WITH SECONDARY AML BLUT, 1986, 53 (03): : 141 - 141
- [32] DOES THE METABOLITE URACIL ARABINOSIDE INHIBIT CYTOSINE-ARABINOSIDE (ARA-C) PENETRATION INTO THE CEREBROSPINAL-FLUID DURING HIGH-DOSE ARA-C THERAPY SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1986, 36 (01): : 123 - 126
- [33] RELATIONSHIP BETWEEN PLASMA ARA-C AND INTRACELLULAR ARA-CTP POOLS UNDER CONDITIONS OF CONTINUOUS INFUSION AND HIGH-DOSE ARA-C TREATMENT MEDICAL AND PEDIATRIC ONCOLOGY, 1982, : 33 - 43
- [35] NOVANTRONE AND HIGH-DOSE ARA-C (NOAC) AS SALVAGE THERAPY FOR RESISTANT NON-HODGKIN-LYMPHOMA BLUT, 1988, 57 (04): : 252 - 252
- [36] PHARMACOLOGICAL BASIS FOR THE THERAPEUTIC INDEX OF HIGH-DOSE ARA-C - IMPLICATIONS FOR COMBINATIONS PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 174 - 174
- [37] MODULATION OF THE CELLULAR PHARMACOLOGY OF HIGH-DOSE ARA-C (HIDAC) BY ASPARAGINASE (ASNASE) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 409 - 409
- [40] EFFECT OF THYMIDINE AND HYDROXYUREA ON HIGH-DOSE ARA-C METABOLISM AND CYTOTOXICITY IN HIGHLY ARA-C RESISTANT HUMAN-LEUKEMIC CELLS PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 325 - 325